- Home
- MOLN vs KNOP Comparison
MOLN vs KNOP Comparison
Compare MOLN & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- KNOP
- Stock Information
- Founded
- MOLN 2004
- KNOP 2013
- Country
- MOLN Switzerland
- KNOP United Kingdom
- Employees
- MOLN N/A
- KNOP N/A
- Industry
- MOLN
- KNOP Marine Transportation
- Sector
- MOLN
- KNOP Consumer Discretionary
- Exchange
- MOLN Nasdaq
- KNOP Nasdaq
- Market Cap
- MOLN 192.4M
- KNOP 187.6M
- IPO Year
- MOLN 2021
- KNOP 2013
- Fundamental
- Price
- MOLN $5.04
- KNOP $5.62
- Analyst Decision
- MOLN
- KNOP
- Analyst Count
- MOLN 0
- KNOP 0
- Target Price
- MOLN N/A
- KNOP N/A
- AVG Volume (30 Days)
- MOLN 5.7K
- KNOP 72.3K
- Earning Date
- MOLN 03-13-2025
- KNOP 02-24-2025
- Dividend Yield
- MOLN N/A
- KNOP 1.87%
- EPS Growth
- MOLN N/A
- KNOP N/A
- EPS
- MOLN N/A
- KNOP N/A
- Revenue
- MOLN $7,105,397.00
- KNOP $299,790,000.00
- Revenue This Year
- MOLN N/A
- KNOP $7.66
- Revenue Next Year
- MOLN $29.41
- KNOP $1.75
- P/E Ratio
- MOLN N/A
- KNOP N/A
- Revenue Growth
- MOLN N/A
- KNOP 4.75
- 52 Week Low
- MOLN $3.32
- KNOP $4.94
- 52 Week High
- MOLN $12.70
- KNOP $9.11
- Technical
- Relative Strength Index (RSI)
- MOLN 41.97
- KNOP 44.69
- Support Level
- MOLN $5.22
- KNOP $5.42
- Resistance Level
- MOLN $5.35
- KNOP $5.79
- Average True Range (ATR)
- MOLN 0.12
- KNOP 0.18
- MACD
- MOLN -0.03
- KNOP -0.04
- Stochastic Oscillator
- MOLN 0.00
- KNOP 38.24
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.